The results showed that ITGB2-related signal pathway expression was significantly upregulated in high-grade ovarian cancer samples (FIGO III/IV) compared with low-grade ones (Figure 2A, 2B). The gene discussed is ITGB2; the disease is ovarian carcinoma.